Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21565490

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2011 Jul
First author
Pelzer U

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Pelzer U
      type
      Author
    2. name
      Schwaner I
      type
      Author
    3. name
      Stieler J
      type
      Author
    4. name
      Adler M
      type
      Author
    5. name
      Seraphin J
      type
      Author
    6. name
      Dörken B
      type
      Author
    7. name
      Riess H
      type
      Author
    8. name
      Oettle H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Pelzer U
      type
      Author
    2. name
      Schwaner I
      type
      Author
    3. name
      Stieler J
      type
      Author
    4. name
      Adler M
      type
      Author
    5. name
      Seraphin J
      type
      Author
    6. name
      Dörken B
      type
      Author
    7. name
      Riess H
      type
      Author
    8. name
      Oettle H
      type
      Author
    bibliography ids
    1. nci-bib-8d4c3196eab5e353fdc74091
    book metadata
    content sha256
    d2d85897c9f118f30fe99e8ce18855040a5695e1e227c36d4f6b19eb583ab947
    document type
    citation
    dois
    1. 10.1016/j.ejca.2011.04.011
    electronic publication date
    display
    2011 May 10
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21565490
    immutable id
    pubmed:21565490@d2d85897c9f118f30fe99e8ce18855040a5695e1e227c36d4f6b19eb583ab947
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    11
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    1676-81
    volume
    47
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21565490
      provenance
      batch id
      a366a1bc8ed89d8d7ca5
      provider
      NCBI PubMed ESummary
      record sha256
      b89a0f631253381db95dde2f5dc28d76c77578c51d5e76da1ddc34c78e38e1a3
      response sha256
      c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
      retrieved at
      2026-09-09T23:46:40.540025+00:00
      publication date
      display
      2011 Jul
      precision
      month
      year
      2011
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21565490/
      title
      Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

      Preserved source evidence · Not medical advice